Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation
about
Substitution of the Rev-response element in an HIV-1-based gene delivery system with that of SIVmac239 allows efficient delivery of Rev M10 into T-lymphocytes.In vitro expression of the HIV-2 genomic RNA is controlled by three distinct internal ribosome entry segments that are regulated by the HIV protease and the Gag polyproteinDestiny of Unspliced Retroviral RNA: Ribosome and/or Virion?High Frequency of Genetic Recombination Is a Common Feature of Primate Lentivirus ReplicationHuman immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2The retroviral RNA dimer linkage: different structures may reflect different rolesCoordination of Genomic RNA Packaging with Viral Assembly in HIV-1Wrapping up the bad news: HIV assembly and releaseThe matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag.Cross- and Co-Packaging of Retroviral RNAs and Their ConsequencesOrchestrating the Selection and Packaging of Genomic RNA by Retroviruses: An Ensemble of Viral and Host FactorsThe Life-Cycle of the HIV-1 Gag-RNA ComplexTsg101, an inactive homologue of ubiquitin ligase e2, interacts specifically with human immunodeficiency virus type 2 gag polyprotein and results in increased levels of ubiquitinated gag.Translation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells.Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus.Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus.Partial restoration of replication of simian immunodeficiency virus by point mutations in either the dimerization initiation site (DIS) or Gag region after deletion mutagenesis within the DIS.Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virionsNovel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequencesMolecular mechanisms of simian immunodeficiency virus SIV(agm) RNA encapsidationOptimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gagHIV-2 genomic RNA accumulates in stress granules in the absence of active translation.The retrovirus RNA trafficking granule: from birth to maturity.The simian immunodeficiency virus 5' untranslated leader sequence plays a role in intracellular viral protein accumulation and in RNA packaging.Diverse interactions of retroviral Gag proteins with RNAs.Mechanisms of human immunodeficiency virus type 2 RNA packaging: efficient trans packaging and selection of RNA copackaging partners.SHAPE analysis of the FIV Leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization.HIV-2 genome dimerization is required for the correct processing of Gag: a second-site reversion in matrix can restore both processes in dimerization-impaired mutant virusesSequence requirements for localization and packaging of Ty3 retroelement RNA.Important role for the CA-NC spacer region in the assembly of bovine immunodeficiency virus Gag protein.Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro.Structural dynamics of retroviral genome and the packagingEncapsidation determinants located downstream of the major splice donor in the maedi-visna virus leader regionA new type of IRES within gag coding region recruits three initiation complexes on HIV-2 genomic RNADifferent effects of the TAR structure on HIV-1 and HIV-2 genomic RNA translation.The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity.Mapping the encapsidation determinants of feline immunodeficiency virus.The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycleAccuracy estimation of foamy virus genome copying.
P2860
Q21245027-3B7D27D1-3E5D-4195-81BD-62DBFCE2C4A5Q22241577-85E4A8FB-BA3E-4C28-BFC5-70807EFDD627Q22242227-22FC0CE2-E1C3-41DB-BE64-92FCCD2081C8Q22242228-2DF3C487-C393-4E37-8AA2-DA75857CC0A5Q24305530-7AC326C6-ED57-4AA9-96C1-EC044A2666DBQ24805913-6073F502-394A-4416-B0AB-2A82054014D5Q26739673-C0B7ACA4-0FB0-4A06-8F86-B0AFDBBCBFBFQ26992150-49E9C4FE-8BD6-44EF-B258-2424B3094C5AQ27303006-31EFB744-9B69-4E42-856A-D926E8C1E068Q28066817-BCE63EA3-39E6-40EE-A19B-D3C80B490F07Q28074165-718ABF77-8AAC-4AED-91C9-7E31BF988EA8Q28076985-0238B413-ACAF-4980-A156-6199B83D0A93Q30865002-36D94C04-FEF3-4131-9E4A-7022CE666765Q30968445-7954B006-0EBD-4A04-AB82-CCB410DCAAC6Q33604023-BE626689-64C9-4EA7-83AC-F23D7ADDAE9CQ33827534-1EE602D2-B7AE-4CD4-B3C0-92476C46615AQ33850330-9557FA13-9287-460B-959E-B2530E5A2092Q33851781-925D04E7-9170-4CD9-B044-47E9ABE08932Q33865700-562F0BA1-F679-41D2-AB1F-CFA77336D6C0Q34062113-F7FCC5BB-FAEA-4B5A-8410-ED2F0E01AA29Q34329784-8563FA25-FBF7-4D45-B399-C60A677E03A7Q34489574-545628D7-ABEB-4E08-A14B-895897E51D6DQ34667412-727B4C11-AFBE-452B-ABA3-0560A460B1EEQ34996384-ADE5D49D-4902-4613-8284-547287131B7DQ35087489-E4B21C80-33B7-46CD-87BF-3889786A8EF4Q35140343-CB6F828E-8049-428A-BCED-F16C02412127Q35174691-B5B1B593-4A3F-4973-AA11-DF66CF8743A5Q35943592-E632F482-9164-49F9-A044-8D4AD126C1A6Q36626099-D466E4AA-1EB3-4544-AC5E-7FD67760E472Q36943348-ACA2F324-0C68-436B-9954-5EF05625033FQ37131965-9EBD1434-397A-4695-92D7-C8F79CD45FA2Q37509306-B0FD7D12-F580-4E13-A3EA-08C3DF4ED5E6Q37974642-15259412-83CD-47B3-AB12-D98AAF2438D4Q39321671-87F9A6A5-ACE7-40C5-9DAA-E87FBC41056DQ39373897-6DFBC944-3591-483F-906F-CF5FBC6E4292Q39436460-D799B5E4-2F08-424D-9C30-8A96EF11A67BQ39611117-92BEE3AB-0110-4A3B-87C8-64FEE82A6218Q39686316-A46ED42A-5859-4DC3-A715-4BAD0CA89538Q39736726-5E6BA0BE-B453-48AA-AD1C-FEC361BBBE2CQ39863795-3E0FA26F-DE81-4C50-BB5A-65FC0FCBBFD2
P2860
Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Human immunodeficiency virus t ...... genomic RNA for encapsidation
@ast
Human immunodeficiency virus t ...... genomic RNA for encapsidation
@en
type
label
Human immunodeficiency virus t ...... genomic RNA for encapsidation
@ast
Human immunodeficiency virus t ...... genomic RNA for encapsidation
@en
prefLabel
Human immunodeficiency virus t ...... genomic RNA for encapsidation
@ast
Human immunodeficiency virus t ...... genomic RNA for encapsidation
@en
P2860
P1433
P1476
Human immunodeficiency virus t ...... genomic RNA for encapsidation
@en
P2093
P2860
P304
P577
1999-04-01T00:00:00Z